Fintel reports that on January 29, 2025, Truist Securities initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a ...
Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...
As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...
Influence Media Partners has confirmed that it has secured approximately $360 million in debt financing through an inaugural ...
Silgan Holdings Inc. ( NYSE: SLGN) Q4 2024 Earnings Conference Call January 29, 2025 11:00 AM ET ...
Omega Healthcare Investors Inc.-3.88% $10.16B ...